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The fungal arginine attenuator peptide (AAP) is encoded by a regulatory upstream open reading frame (uORF). The AAP acts as
a nascent peptide within the ribosome tunnel to stall translation in response to arginine (Arg). The effect of AAP and Arg on ri-
bosome peptidyl transferase center (PTC) function was analyzed inNeurospora crassa and wheat germ translation extracts using
the transfer of nascent AAP to puromycin as an assay. In the presence of a high concentration of Arg, the wild-type AAP inhib-
ited PTC function, but a mutated AAP that lacked stalling activity did not. While AAP of wild-type length was most efficient at
stalling ribosomes, based on primer extension inhibition (toeprint) assays and reporter synthesis assays, a window of inhibitory
function spanning four residues was observed at the AAP’s C terminus. The data indicate that inhibition of PTC function by the
AAP in response to Arg is the basis for the AAP’s function of stalling ribosomes at the uORF termination codon. Arg could inter-
fere with PTC function by inhibiting peptidyltransferase activity and/or by restricting PTC A-site accessibility. The mode of PTC
inhibition appears unusual because neither specific amino acids nor a specific nascent peptide chain length was required for AAP
to inhibit PTC function.
Translational control mediated by nascent peptides is demon-strated in mammals, fungi, plants, bacteria, and viruses (25,
28, 30, 40, 43, 46, 62). Among regulatory nascent peptides that
control gene expression are some that are encoded by upstream
open reading frames (uORFs) in mRNA 5= leaders. The signifi-
cance of eukaryotic uORFs is increasingly appreciated (2, 11, 14,
22, 35). Translation of uORFs can reduce translation of down-
stream ORFs and also decrease mRNA stability. Regulation by
eukaryotic uORFs and prokaryotic leader peptides (the designa-
tion for prokaryotic uORFs) has consequences for a variety of
physiological processes (3, 27).
Regulatory nascent peptides can control translation from
within the ribosome tunnel by causing ribosomes to stall. In Esch-
erichia coli, tryptophanase expression is controlled in response to
tryptophan by the TnaC leader peptide which acts as a ribosome
arrest peptide (RAP) during translation termination (13). E. coli
SecM and Bacillus subtilisMifM nascent polypeptides contain do-
mains that interact with the ribosome to cause ribosome arrest
during elongation (8, 38, 51, 52). Bacterial erm and cml operons,
which confer resistance to macrolides and to chloramphenicol,
respectively, are regulated by nascent leader peptides that function
as RAPswhen the antibiotics are present (16, 31, 32, 44). A nascent
peptide designated MTO1 within the Arabidopsis thaliana CGS1
coding region causes ribosomes to stall during elongation in re-
sponse to S-adenosyl-L-methionine; the stall induces mRNA deg-
radation (10, 39). Inmammals, the uORF-encodedRAPMAGDIS
regulates the synthesis of S-adenosylmethionine decarboxylase in
response to polyamines by stalling ribosomes (45, 48). Expression
of the human cytomegalovirus (CMV) gp48 gene is reduced by
translation of its uORF2RAP (29), which causes ribosomes to stall
at the uORF2 termination codon (5, 6). Ribosomes synthesizing
the uORF-encoded fungal arginine attenuator peptide (AAP) stall
at the uORF termination codon in response to a high concentra-
tion of arginine (Arg) (17, 19, 26, 53–56, 60).
The regulatory AAP uORF is present in the 5= leaders of fungal
mRNAs specifying the glutamine amidotransferase subunit of
Arg-specific carbamoyl phosphate synthetase (26, 57). AAP-me-
diated stalling in response to Arg results in the reduced synthesis
of the first enzyme specific for Arg biosynthesis (15). AAP is the
best-understood example of a eukaryotic RAP. In vivo studies of
the Neurospora crassa arg-2 mRNA, which encodes the AAP
uORF, show that the rate of ARG-2 synthesis is reduced in Arg-
supplemented medium (33). Polysome profile analyses show that
adding Arg to the growth medium shifts the N. crassa arg-2 and
Saccharomyces cerevisiae CPA1 transcripts that specify the wild-
type (WT) uORF-encoded AAP toward the monosome fraction
(20, 34). Furthermore, in S. cerevisiae, ribosome stalling at the
uORF termination codon triggers degradation of the mRNA
through the nonsense-mediated mRNA decay pathway (20).
Thus, AAP-mediated ribosome stalling can regulate gene expres-
sion in cis by reducing translation from a downstream start codon
in the mRNA and by reducing the stability of this mRNA.
In vitro experiments have contributed to an understanding of
the mechanistic basis of AAP function. Toeprinting (primer ex-
tension inhibition), which maps the positions of ribosomes on
mRNA, shows that when the AAP functions as a uORF, ribosomes
arrested at the AAP termination codon block scanning ribosomes
from reaching the downstream initiation codon for the genicORF
(21). AAP can also function as an internal polypeptide domain to
cause stalling of ribosomes during elongation (17, 60). AAP causes
Arg-regulated stalling of fungal, plant, and animal ribosomes, es-
tablishing that the AAP and Arg exploit highly conserved ribo-
some functions to cause stalling (17). Ribosomal peptidyl trans-
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ferase function is a likely target, but this has not yet been directly
demonstrated.
Structurally, site-specific photo-cross-linking experiments in-
dicate that Arg alters the conformation of the wild-type AAP rel-
ative to the ribosome tunnel (61). In high concentrations of Arg
(high Arg), a cross-linker placed at AAP Val-7 reacted relatively
less to ribosomal protein L17 and more to ribosomal protein L4.
Consistent with these data, visualization of ribosome nascent
chain complexes containing AAP in the absence of Arg by cryo-
electron microscopy (cryo-EM) also indicates that the AAP inter-
acts with ribosomal proteins L4 and L17 at the ribosome tunnel
constriction (1).
A hypothesis to explain Arg-regulated ribosome stalling by
AAP is that high Arg stabilizes a conformation of the nascent
peptide relative to the ribosome that interferes with PTC function,
resulting in ribosome stalling. To test this, we used a puromycin
release assay to directly examine how the AAP and Arg affect PTC
function. Puromycin is an aminonucleoside antibiotic in which
part of the molecule resembles the 3= end of tyrosyl-tRNA (24).
During translation, puromycin enters the PTC A site, and the
peptidyl transferase reaction transfers the nascent peptide from
tRNA to puromycin. The rate of nascent peptide chain transfer to
puromycin thus can be used as an indicator of PTC function (12,
23, 36, 37, 58, 59, 63).
Here, we show that AAP functions with Arg to interfere with
the PTC function ofN. crassa and wheat ribosomes. AAP contain-
ing the D12N mutation, which eliminates Arg-induced ribosome
stalling, also eliminated Arg’s effect on PTC function. Impor-
tantly, the AAP interfered with the PTC before full-length AAP
was synthesized, but full-length synthesis appeared important for
most efficient stalling. These data support a model for AAP func-
tion in which the inhibition of PTC function is the basis for the
AAP’s capacity to stall the ribosome. Unlike many other RAPs,
specific features of the AAP near the ribosomal catalytic center
appear relatively unimportant for stalling.
MATERIALS AND METHODS
Plasmids. Plasmids containing the coding sequences for wild-type
Met9AAP (pJC102) (where Met9AAP is an AAP construct with eight ad-
ditional Met codons at the N terminus of the AAP) (see Fig. S1A in the
supplemental material) and D12NMet9AAP (pJCS102) were constructed
as described previously (61). Thewild-typeAAP sequencewas replaced by
other sequences by replacing the small AgeI-HindIII restriction fragments
with annealed synthetic oligonucleotides by ligation (see Table S1 in the
supplementalmaterial). To construct plasmid pJW201 (see Fig. S1B in the
supplemental material), which contains the uORF-encoded AAP and a
downstream luciferase reporter, synthetic complementary oligonucleo-
tides JW001 and JW001 (see Table S2 in the supplemental material)
were annealed and ligated to gel-purified vector pR301 (18) that had been
digested with MluI and NcoI. Mutations were introduced into the AAP
coding sequence by replacing the small SpeI-HindIII restriction fragment
with annealed synthetic oligonucleotides by ligation (see Table S2 and Fig.
S1B). To construct plasmid pJF401 (see Fig. S1C), which contained the
AAP fused in framewith a luciferase reporter (AAP-LUC), synthetic com-
plementary oligonucleotides (see Table S3 in the supplemental material)
were annealed and ligated to gel-purified vector pJW201 that had been
digested with SpeI and BstEII. Mutations were introduced into the AAP
coding sequence by replacing the SpeI-BstEII restriction fragment with
annealed synthetic oligonucleotides by ligation (see Table S3 and Fig.
S1C). Plasmids specifying T7LUC and sea pansy luciferase were described
previously (53, 55).
RNAsynthesis.Capped and truncatedmRNAs encoding nascent pep-
tides were transcribed in vitro by T7 RNA polymerase (60) using PCR-
generated DNA fragments as templates (primers are listed in Table S4 in
the supplemental material). Capped and polyadenylated RNAswere tran-
scribed in vitro by T7 RNA polymerase from plasmid DNA templates that
were linearized with EcoRI (18). Aliquots of transcribed RNAs were elec-
trophoresed in agarose gels adjacent to nucleic acid standards of known
quantity and stainedwith ethidiumbromide.Gel imageswere obtained by
a GE Typhoon Trio imager and analyzed by ImageQuantTL to deter-
mine the relative amounts of RNA.
Cell-free translation analyses. To visualize peptidyl-tRNA by
[35S]Met labeling, in vitro translation reactions (20l) were programmed
with 120 ng of RNA. Either micrococcal nuclease-treated N. crassa ex-
tracts or micrococcal nuclease-treated wheat germ extracts were used
(61). [35S]Met (1,000Ci/mmol;MPBiomedicals) was added to reaction
mixtures at a final concentration of 0.5 Ci/l. Arg or Arg analogs were
added to reactionmixtures as described in the text. For puromycin release
assays, translation reaction mixtures were incubated for 5 min at 26°C,
and then puromycin at concentrations indicated in the text was added to
reaction mixtures. Samples (5 l) were taken immediately before the ad-
dition of puromycin and at time points following addition as indicated
(see, for example, Fig. 1A). Samples were mixed with 5l of 2NuPAGE
LDS sample buffer (Invitrogen) and put on ice to stop reactions and then
analyzed using 12% NuPAGE gels (Invitrogen) with morpholineethane-
sulfonic acid (MES) running buffer. The gels were fixed and dried, ex-
posed to phosphor screens overnight, and analyzed with a GE Typhoon
Trio imager and ImageQuantTL software.
To visualize peptidyl-tRNA by 32P probing, in vitro translation reac-
tion mixtures (20 l) were prepared as described above, except that reac-
tion mixtures contained 20 MMet and no [35S]Met. Following gel elec-
trophoresis, samples were transferred to Zeta-Probe nylon membranes
(Bio-Rad). The procedures for electrophoretic transfer, nucleic acid fixa-
tion on the membrane, prehybridization, hybridization with 32P-labeled
oligonucleotide, and washing were as described previously (50), except
that denatured salmon spermDNAwas not included in the prehybridiza-
tion and hybridization solutions. After membranes were washed, they
were exposed to phosphor screens overnight. The DNA probe (JW02,
5=-GATCCACCCAGGGGTCG-3=), which is the reverse complement to
nucleotides (nt) 56 to 72 ofN. crassa tRNAArg (CGU) (41), was 32P labeled
at its 5= end as described previously (54).
For luciferase reporter assays, the reaction conditions for in vitro
translation using N. crassa extracts were as described previously (56).
Translation reaction mixtures (10 l) were incubated at 25°C for 30 min,
and translation was halted by adding 50 l of 1.2 passive lysis buffer
(Promega). For firefly luciferase activity measurements, equal amounts
(12 ng) of mRNA encoding firefly luciferase were used to program ex-
tracts; 2.5 ng of synthetic mRNA encoding Renilla (sea pansy) luciferase
was added to all reaction mixtures to serve as an internal control (53).
Firefly and sea pansy luciferase enzyme activities were measured using a
Dual-Luciferase Reporter Assay System (Promega) with a Victor 3 Mul-
titask plate reader (Perkin Elmer).
The primer extension inhibition (toeprint) assays were accomplished
using 32P-labeled primer ZW4 as described previously (47, 56), except
that when cycloheximide (CYH) was added to the reaction mixture after
10 min of translation, reactions were immediately processed to preserve
signals from ribosomes stalled at termination codons.
RESULTS
AAP interferes with PTC function in response to Arg.We tested
whether the AAP directly interfered with PTC function using pu-
romycin release as an assay (Fig. 1A). Cell-free translation extracts
were programmed with truncated synthetic mRNA specifying
wild-type or mutated AAPs. Ribosomes that translate the AAP
coding sequence are expected to accumulate at the 3= end of the
mRNA with the last codon in the P site. The nascent AAP would
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FIG 1 Puromycin release assay to assess the effects of AAP and Arg on PTC function. (A) Synthetic truncated mRNA specifying theN. crassa AAP is translated
in cell-free systems. Because the mRNA lacks in-frame stop codons, the full-length nascent peptide should remain associated with ribosomes as peptidyl-tRNA
with the last encoded amino acid in the ribosome P site. After translation at 26°C for 5 min, puromycin is added to the reaction mixture. Samples are taken
immediately before the addition of puromycin (time zero) or at 1 and 3 min following the addition. Translation products are analyzed on 12% NuPAGE gels.
Translation reactionmixtures contained either low () Arg (20M) or high () Arg (2 mM). (B) Puromycin release assay to examine the functions ofWT and
D12N AAPs in wheat germ extract. Translation reaction mixtures contain either low () or high () Arg. Samples were taken at time zero and at 1 and 3 min
after the addition of 1 mM puromycin. Lane 13 represents a control reaction mixture to which no mRNA was added. Arrow, [35S]Met-labeled AAP-tRNA that
was resistant to puromycin release in high Arg; arrowhead, [35S]Met-labeled free AAP and AAP-puromycin. (C) Quantification of the puromycin release assay
ofWT andD12NAAP-tRNAs inwheat germ extract. The signals representing AAP-tRNAs at 1 and 3minwere normalized to the signal at time zero.Mean values
and standard deviations from three independent experiments are given (***, P 0.001, Student’s t test). (D) Puromycin release assay to compare the effect of
translating truncated mRNA to mRNA with a 3= poly(A) tail in wheat germ and N. crassa extracts. mRNAs encoding WT and D12N AAPs were used. Samples
were taken at time zero and at 1 and 3min after the addition of 1mMpuromycin (wheat germ extract) or 0.1mMpuromycin (N. crassa extract). A representative
result of triplicate experiments is shown. Trunc, truncated mRNA; 3= p(A), mRNA with an intact AAP stop codon and a 3= poly(A) tail. (E) Puromycin release
assay inN. crassa extract. Samples were taken at time zero and at 1 and 3min after the addition of 0.1 mMpuromycin. A24R, D12N A24R,WT, and D12NAAPs
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thus be in peptidyl-tRNA form at the P site. The AAP is visualized
by [35S]Met labeling; eight additional Met residues are encoded at
the AAP’s N terminus to increase labeling (19). After translation
of the RNA for 5 min at 26°C in either low (20 M) or high (2
mM) Arg concentrations, puromycin is added to the reaction
mixtures. Samples are taken immediately before the addition of
puromycin (time zero [T0]) and at 1-min and 3-min time points
following puromycin addition (Fig. 1A). The [35S]Met-labeled re-
action products are analyzed using 12% NuPAGE gels. AAP-
tRNA and AAP released from tRNA can thus be resolved, and the
amount of [35S]Met in AAP-tRNA form can be quantified.
The addition of Arg lowered the rate of puromycin-induced
release of wild-type (WT) AAP-tRNA in wheat germ extract (Fig.
1B). In a low concentration of Arg (low Arg), WT AAP-tRNA,
whichmigrated with an apparentmass of28 kDa andwhichwas
RNase sensitive (see Fig. S2 in the supplemental material), disap-
peared rapidly following the addition of 1 mM puromycin (Fig.
1B, lanes 3 and 5 versus lane 1; quantification is given in Fig. 1).
The decrease in the AAP-tRNA species in response to puromycin
was accompanied by an increase in the AAP (mass of 3.8 kDa;
the AAP is expected to be linked to puromycin, whose mass did
not have a detectable impact on the AAPs’ migration in this gel
system). This indicated that in low Arg, the PTC relatively effi-
ciently transferred the nascent AAP from AAP-tRNA to puromy-
cin. However, in a high concentration of Arg (high Arg), WT
AAP-tRNA did not decrease as rapidly in response to puromycin,
indicating that Arg interfered with PTC function (Fig. 1B, lanes 4
and 6 versus lane 2; quantification in Fig. 1). The difference in
puromycin release rates in low versus high Arg was significant (P
 0.001, Student’s t test). TheWTAAP-tRNA band was stronger,
and the free AAP band was weaker in high Arg even before
puromycin treatment (Fig. 1B, lane 2 versus lane 1), which is
also consistent with Arg having a stabilizing effect on the nas-
cent WT AAP-tRNA in the ribosome. In other words, the in-
creased level of WT AAP-tRNA in the presence of high Arg
could reflect reduced spontaneous hydrolysis of the peptidyl-
tRNA (42). Asp-12 of AAP is functionally important, and the
D12N mutation abolishes AAP-mediated stalling in response
to Arg (reference 49 and references therein). For the nonfunc-
tional D12N AAP, AAP-tRNA disappeared rapidly in response
to puromycin in both low Arg (Fig. 1B, lanes 9 and 11 versus
lane 7; quantification in Fig. 1) and high Arg (Fig. 1B, lanes 10
and 12 versus lane 8; quantification in Fig. 1), indicating that
Arg did not affect PTC function when ribosomes contained
D12N AAP-tRNA. These data show that the D12N AAP did not
inhibit PTC function in response to Arg.
The data in Fig. 1B show AAP-tRNA as a doublet band. This
doublet was RNase sensitive (see Fig. S2 in the supplemental ma-
terial), but only the upper band (arrow) was stabilized for WT
AAP in high Arg concentrations. To assess whether the doublet
occurred as a consequence of using truncated RNA as a template
for translation and to test whether the PTC ofN. crassa ribosomes
is also inhibited byAAP in highArg, we comparedwheat germand
N. crassa translation extracts programmedwith truncated RNA or
poly(A) mRNA (Fig. 1D). The poly(A) mRNA contained an AAP
with a termination codon and a 3= untranslated region (UTR).
Overall, the truncated mRNAs encoding the WT AAP and the
D12N AAP behaved similarly to the corresponding poly(A)
mRNAs in both extracts (Fig. 1D): theWTAAP-tRNA species but
not theD12NAAP-tRNA species showed resistance to puromycin
release in high Arg. In wheat germ extract, the upper band of the
doublet was more resistant to puromycin; inN. crassa extract, the
lower band was more resistant. The difference between wheat and
N. crassa extracts could be expected to reflect differences in the
tRNAs of these organisms. Furthermore, in extracts programmed
with poly(A) RNA, the band that was not stabilized by Arg forWT
AAP in response to puromycin was reduced overall. Based on
these results and the data described below, this second bandmight
represent ribosomes whosemovement is blocked by the ribosome
either at the 3= end of the truncated RNA or at the uORF termi-
nation codon.While the identity of this second band has not been
elucidated, we confirmed, as shownnext, that inN. crassa extracts,
the puromycin-resistant band (lower band) corresponded to full-
length AAP-tRNA.
We examined Arg-specific regulation of AAP-tRNA release
both by [35S]Met labeling of the peptide and by 32P probing of the
tRNA inN. crassa extract. [35S]Met labeling (Fig. 1E) showed that
A24R AAP (AAP with a CGU-encoded Arg at its C terminus)
functioned similarly to WT AAP (AAP with a GCG-encoded Ala
at its C terminus) to inhibit puromycin release in high Arg. D12N
A24RAAP andD12NAAPdid not respond to Arg (Fig. 1E). Thus,
consistent with observations that A24RAAP is functional for stall-
ing (49), the A24Rmutation at the C terminus of the AAP did not
affect the AAP’s ability to regulate PTC function. Next, samples
that lacked [35S]Met were probed with a 32P-labeled oligonucleo-
tide, complementary to N. crassa tRNAArg (CGU) (41). The pep-
tidyl-tRNAbands of A24RAAP andD12NA24RAAP but notWT
AAP were detected (Fig. 1E), and A24R AAP-tRNA was resistant
to puromycin release in high Arg. These data showed that Arg
stabilized the functional AAP that was fully synthesized from
truncated RNA. AAP-tRNA appeared as a single band by tRNA-
probing, not as a doublet, and based on its position relative to
polypeptide size markers, this band corresponded to the lower
band of the doublet observed by [35S]Met labeling in N. crassa
extract. We confirmed the specificity of the CGU probe by show-
ing that it did not recognize AAP-tRNA with a C-terminal CGC
Arg-codon (see Fig. S3 in the supplemental material).
We next examined the effect on puromycin release of adding
high Arg concentrations to reactionmixtures in which full-length
AAPwas synthesized in lowArg concentrations (Fig. 1F). Previous
work indicates that the relative conformation of the AAP changes
with respect to the ribosome under these conditions (61). We
added edeine, which blocks translation initiation, after 5 min of
translation to stop new synthesis of AAP. Oneminute later, 2 mM
Arg was added, and 5 min after that, the puromycin release assay
was performed. The results of adding 2 mM Arg after edeine ad-
were analyzed. AAP-tRNA was labeled with [35S]Met (left), or a 32P-labeled tRNAArg (CGU) probe (right) was used. A representative result of triplicate
experiments is shown. (F) Adding Arg after AAP synthesis to assess the regulatory effect on PTC function. The puromycin release assay was performed as shown
in the upper panel. After translation in wheat germ for 5 min, edeine was added to block translation initiation. Arg (2 mM) was added either before translation
was started or after the addition of edeine. The effects on puromycin-induced release of nascent peptidewere compared to a reactionmixture that did not contain
high Arg.
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dition were similar to those of adding 2 mM Arg at the beginning
of translation; in each case, PTC function was inhibited relative to
a reaction mixture containing a low concentration of Arg (Fig.
1F). These data indicate that a high concentration of Arg can in-
duce a change in the PTC of ribosomes that have synthesized AAP
in low Arg.
Parameters that affect Arg- and AAP-mediated inhibition of
PTC function. We next examined effects of different parameters
on the efficiency of puromycin release inwheat germ andN. crassa
extracts. The effects of different puromycin concentrations were
tested (see Fig. S4A in the supplemental material). In both ex-
tracts, 0.025 mM puromycin appeared sufficient in low Arg to
effectively release the nascent AAP from the tRNA at the 3-min
time point. In wheat germ extract, varying the concentration of
puromycin from 0.025 mM to 1 mM had little impact on Arg’s
inhibitory effect on puromycin release. However, in N. crassa ex-
tract, when the concentration of puromycin was greater than 100
M, we did not observe an effect of Arg, indicating that the kinet-
ics of release were too rapid relative to the time points that were
sampled. This difference in sensitivity of puromycin releasemight
be due to differences in the overall sensitivity of these translation
extracts to puromycin. The N. crassa extract was more sensitive
than the wheat germ extract to puromycin, based on the ability to
synthesize luciferase in the presence of increasing amounts of pu-
romycin (see Fig. S4B in the supplemental material). We used 1
mM puromycin with wheat germ extract and 0.1 mM puromycin
with N. crassa extract.
The effect of Arg concentration on puromycin release was
tested next (Fig. 2A). We observed increased inhibition of WT
AAP-tRNA release as the concentration of Arg increased from
0.25mM to 2mM in wheat germ extract. Was this due to nonspe-
cific electrostatic effects of Arg? To test this, we compared the
effects of adding either 2 mMArg or a 2 mM concentration of the
stereoisomer D-Arg on puromycin-release. D-Arg, which does not
induce stalling (49), also had no discernible impact on puromy-
cin-induced release (Fig. 2B), showing that the effect of Arg on
PTC function required L-Arg.
Although D-Arg did not directly induce regulation by the AAP,
it was possible that it could competitively inhibit Arg’s capacity to
induce regulation. We tested this inN. crassa extract by analyzing
the effects of increasing concentrations of Arg on the synthesis of
a firefly luciferase reporter in the presence or absence of 2 mM
D-Arg (Fig. 2C). The ability of the uORF-encoded AAP to down-
regulate firefly luciferase reporter synthesis is a measurement of
ribosome stalling at the uORF (55). As observed previously, Arg
regulation by AAP was relatively efficient, and addition of Arg at
concentrations ranging from 0.25 mM to 2 mM significantly re-
duced luciferase synthesis (P 0.001, Student’s t test). Addition of
2 mM D-Arg as a competitive inhibitor at each of these Arg con-
centrations did not interfere with regulation. In addition, when
D-Arg was added to translation reaction mixtures with 0.5 mM
Arg or 2 mM Arg, puromycin-induced release of AAP-tRNA was
not affected (Fig. 2D, lanes 6, 9, 15, and 18 versus lanes 5, 8, 14, and
17). Therefore, the effects of Arg on AAP-specific regulation were
stereospecific, and the site(s) at which Arg functioned was not
blocked by D-Arg.
Arg-regulated stalling by the AAP requires that Arg has a freeN
terminus (49). An Arg-Gly-Asp (RGD) tripeptide, which can in-
duceAAP-mediated ribosome stalling (49) and induce a change in
the AAP’s relative conformation in the ribosome (61), also was
inhibitory to puromycin release, albeitmoreweakly thanArg (Fig.
2B). A Gly-Arg-Gly (GRG) tripeptide and Gly-Arg-Gly-Asp
(GRGD) tetrapeptide did not inhibit puromycin release (Fig. 2B).
These data indicate that the free amino group of Arg is important
for the AAP-mediated inhibition of PTC function.
The regulatory functions of extended and shortened AAPs.
Toeprinting analyses indicated that Arg-specific ribosome stalling
was considerably diminished when the N. crassa AAP was short-
ened by a single residue at its C terminus (18). However, C-termi-
nally shortened AAPs still undergo a change in conformation rel-
ative to the ribosome in response to Arg (61). Toeprinting
analyses also indicated that AAPs extended at their C termini re-
tain regulatory activity (18). Since puromycin-induced release is a
direct assay of PTC function, we used this assay to examine the
function of C-terminally extended and shortened AAPs.
Programming wheat germ extracts with truncated mRNAs
specifying AAPs ending at Val-25 (AAP25, in which the AAP stop
codon is changed to a valine codon), Ala-24 (AAP24, the WT
AAP), Asn-23 (AAP23), and Leu-22 (AAP22) showed that each
AAP inhibited puromycin-induced release of the nascent chain in
a high concentration of Arg (Fig. 3A). However, AAPs ending at
Ala-21 (AAP21) or Arg-20 (AAP20) did not inhibit puromycin re-
lease (Fig. 3A). These results indicate that AAPs extended by one
residue or shortened at the C terminus by one or two residues
regulated PTC function in response to Arg, but further shortening
eliminated this regulatory function.
We tested whether C-terminally shortened AAPs were capable
of regulating translation in response to Arg when encoded as
uORFs in the 5= UTRs of capped and polyadenylated luciferase
reporter mRNAs (Fig. 3B). In N. crassa extract, the full-length
wild-type AAP (AAP24) conferred approximately 5-fold regula-
tion; AAP23 and AAP22 conferred approximately 2-fold regula-
tion. AAPs truncated further (AAP21 and AAP20) showed no reg-
ulatory function in response to Arg. Similarly, mRNAs that lacked
the uORF-encoded AAP (T7 LUC) or that contained the D12N
AAP did not show Arg-regulated synthesis of luciferase (Fig. 3B).
These results are consistent with those obtained from the puro-
mycin release assay (Fig. 3A) and indicate that AAPs shortened by
one or two residues still confer regulation in response to Arg.
We next directly examined the capacity of these uORF-en-
coded AAPs to stall ribosomes in N. crassa extracts using the toe-
printing assay, which shows the positions of ribosomes engaged in
the translation of mRNA (Fig. 4C). Cycloheximide (CYH) was
added at 0 min (T0) or 10 min (T10) to increase the signals from
ribosomes at translation initiation sites (20). When CYH was
added at T0, both D12N andWT (AAP24) mRNAs showed similar
levels of ribosomes at the uORF and luciferase (LUC) initiation
codons, either in low or high Arg (Fig. 4C, lanes 5 and 6 and lanes
9 and 10). This is consistent with leaky scanning of ribosomes past
the uORF initiation codon (20). When CYH was added after 10
min, an increased toeprint signal that corresponded to ribosomes
stalled at theAAP24 uORF termination codon and a reduced signal
corresponding to ribosomes at the LUC initiation codon were
observed in extracts containing high Arg (Fig. 3C, lane 12 versus
lane 11). Additional toeprint signals, approximately 30 nt up-
stream of the toeprints for ribosomes stalled at the termination
codon, are interpreted to be ribosomes stalled behind those which
are primarily stalled by Arg (53). These differences in signal inten-
sity were not observed for D12N AAP, which lacks regulatory
activity (Fig. 3C, lane 8 versus lane 7). This is consistent with
Wei et al.












ribosomes stalled at the AAP24 termination codon acting to block
leaky scanning to the downstream LUC initiation codon. As ex-
pected, signals corresponding to ribosomes at initiation or termi-
nation codons were not observed in toeprint analyses of RNA
alone (Fig. 3C, lane 20) or of extract alone (Fig. 3C, lane 19).
Importantly, in reaction mixtures incubated for 10 min, stalling
occurred at the termination codons for AAP23 and AAP22 in high
Arg but at a reduced level compared to stalling at the termination
codon for AAP24 (Fig. 3C, lanes 11 to 16). A high concentration of
Arg also reduced the signal corresponding to ribosomes at the
LUC initiation codon. The AAP21 mRNA in parallel reactions
showedno effect of Arg on stalling at the uORF termination codon
or LUC initiation codon (Fig. 3C, lane 18 versus lane 17). Thus,
with respect to the assessed regulatory activity of truncated AAPs,
toeprinting and luciferase reporter data were qualitatively similar
(Fig. 3B). The toeprinting signal showed ribosomes stalled with
the stop codon in the A site, indicating that the translocation re-
action, which transferred the peptidyl-tRNA from the A site to the
P site, had occurred in the stalled ribosomes (see Fig. 6).
The observations that truncated AAPs interfered with PTC
function suggested that the AAP could inhibit the PTC prior to its
complete synthesis. We directly examined this possibility in N.
crassa extract using tRNAArg probing. Arg (CGU) codons were
strategically placed in mRNAs specifying different truncated
AAPs. As expected, when the last codon was Arg (CGU), L22R
AAP22, N23R AAP23, A24R AAP24, and *25R AAP25 (which has
FIG 2 The effects of Arg concentration and Arg analogs on the puromycin release assay. (A)Wheat germ extract supplemented with different concentrations of
Arg (0.02, 0.25, 0.5, and 2mM)was programmedwith truncatedmRNA specifyingWTAAP. Sampleswere taken at time zero and at 1 and 3min after the addition
of 1 mM puromycin. Arrow, [35S]Met-labeled AAP-tRNA that was resistant to puromycin release in high Arg. In the lower panel, the signals representing
peptidyl-tRNAs at 1 and 3 min were normalized to the signal at time zero in different concentrations of Arg. Mean values and standard deviations from three
independent translation reactions are shown (*, P 0.05; **, P 0.01; ***, P 0.001, Student’s t test). (B) The effect of Arg analogs on the puromycin release
in wheat germ extract programmedwith truncatedmRNA encodingWTAAP., the translation reactionmixture contained lowArg;, the translation reaction
mixture contained a 2 mM concentration of Arg or of the following Arg analogs as indicated: D-Arg, RGD, GRGD, and GRG. In the lower panel, the signals
representing AAP-tRNAs at 1 and 3 min were normalized to the signal at time zero. Mean values and standard deviations from three independent translation
reactions are shown (*,P 0.05; ***,P 0.001, Student’s t test). (C)The effect of Arg concentration onAAP-mediated regulation of luciferase reporter synthesis.
Equal amounts of AAP-LUC mRNA were translated in N. crassa extract supplemented with 0.02, 0.25, 0.5, 1, or 2 mM Arg in the absence or presence of 2 mM
D-Arg. All reactionmixtures containedmRNA for sea pansy luciferase. Firefly luciferase synthesis was first normalized to sea pansy luciferase synthesis. The levels
of synthesis are shown relative to the levels of the extract containing 0.02 mM Arg and no D-Arg. Mean values and standard deviations from three independent
experiments, each performed in triplicate, are given. (D) The effect of D-Arg on the release of peptidyl-tRNA by puromycin. Samples were taken at time zero and
at 1 and 3 min after the addition of 1 mM puromycin to wheat germ extract. D-Arg and Arg were present as indicated. A representative result of triplicate
experiments is shown.
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the AAP stop codon replaced with the Arg (CGU) codon) all
showed regulation in response to Arg based on both [35S]Met and
tRNAArg probing, while A21R AAP21 showed no regulation by
either measurement (Fig. 4A). These data are consistent with the
results obtained for wheat germ extract using [35S]Met labeling
(Fig. 3A). In parallel experiments we observed that for truncated
mRNA encoding L22R AAP24 or N23R AAP24, AAP-tRNA
Arg was
detected and was resistant to puromycin release in high Arg but
not low Arg. These data indicate that Arg regulation of PTC func-
tion occurred prior to full synthesis of the AAP. This was not the
case for A21R AAP24, which showed regulation by [
35S]Met label-
ing but for which tRNAArg was not detected (Fig. 4A). This indi-
cated that translation proceeded efficiently past codon 21 and that
a regulatory “window” inwhich Arg could affect the PTC spanned
from codon 22 to codon 25 of the AAP.
Interestingly, the peptidyl-tRNA of D12N N23R AAP24 was
detected by the tRNAArg probe (Fig. 4A), indicating that transla-
tion was slowed prior to the complete synthesis of this AAP. This
suggested that, independent of the capacity of the AAP to elicit
Arg-regulated stalling, slowing occurs near the AAP C terminus.
This could reflect a general inability of the translation system to
decode truncated RNA, or it could reflect intrinsic stalling activity
of the AAP that was independent of Arg regulation (e.g., that oc-
curred in the presence of the D12N mutation which eliminates
regulation). To examine this, we made a construct specifying a
frameshift AAP (FS AAP) in which only residues 1 to 3 and 23 to
24 were identical to those in the AAP (Fig. 4B). An Arg (CGU)
codon was placed at residue 22, 23, or 24 of WT, D12N, and FS
AAPs. Intrinsic stalling activity was measured by translation of
equal amounts of eachRNA in a low concentration ofArg (Fig. 4B,
lower panel) followed by Northern analysis to detect peptidyl-
tRNA (Fig. 4B, upper panel). As expected for ribosome nascent
chain complex formation on truncated RNA, eachmRNA showed
a strong signal when the Arg codon was the final codon (AAP
FIG 3 The effects of truncating AAP on Arg-specific translational control. (A)
The effect of AAP truncation or extension on puromycin release inwheat germ
extract. Samples were taken at time zero and at 1 and 3 min after the addition
of 1mMpuromycin. Translation reactions were performed in low () or high
() Arg. For the truncated AAPmRNAs used in these experiments, the num-
bers in subscripts indicate the length of the AAP (e.g., AAP24 indicates that
AAPwas truncated after position 24). AAP25 changes the wild-type stop codon
to a valine codon. A representative result of triplicate experiments is shown.
Arrows, positions of [35S]Met-labeled AAP-tRNA that showed resistance to
puromycin-release in high Arg. (B) The regulatory effects of wild-type and
C-terminally truncated AAPs positioned as uORFs in a capped and polyade-
nylated luciferase reporter. uORFs were created with stop codons at AAP po-
sitions 20 to 25 as indicated (e.g., AAP24 contains a stop codon at position 25).
Equal amounts of each mRNA were translated in N. crassa extract containing
low or high Arg. As controls, equal amounts of mRNA encoding firefly LUC
reporter only (T7 LUC) or mRNA containing the D12N AAP uORF were
translated in parallel. All reaction mixtures contained mRNA for sea pansy
luciferase to serve as an internal control for translation. Firefly luciferase syn-
thesis was normalized to sea pansy luciferase synthesis, and then luciferase
synthesis in high Arg was calculated relative to synthesis in low Arg. Mean
values and standard deviations from three independent experiments, each
performed in triplicate, are given. (C) Toeprint analysis to assess Arg regula-
tion by WT, D12N, and truncated AAPs. N. crassa extract was programmed
with equal amounts (60 ng) of mRNA specifying D12N, AAP24 (WT), AAP23,
AAP22, or AAP21 in the 5= leader. mRNAs were those used for luciferase mea-
surements in panel B. Cycloheximide was added either prior to incubation
(T0) or after 10 min of incubation (T10). Radiolabeled primer ZW4 was used
for primer extension analysis and for sequencing the AAP24 template (lanes 1
to 4). The nucleotide complementary to the dideoxynucleotide added to each
sequencing reaction for the AAP24 template is indicated above the correspond-
ing lane so that the sequence of the template can be directly deduced. Asterisks,
toeprint products corresponding to ribosomes stalled at the termination
codon of AAP; arrowheads, toeprint products corresponding to ribosomes
bound at the initiation codons; arrow, toeprint product corresponding to
ribosomes stalled approximately 30 nt upstream of those stalled by Arg at
the termination codon. Boxes (top to bottom): AAP initiation codon, AAP
termination codon, and LUC initiation codon. No EXT, RNA without
extract; no RNA, extract without RNA.
Wei et al.












codon 24) of the truncated RNA (Fig. 4B, lanes 3, 6, and 9).When
the Arg codon was at AAP codon 22 or codon 23, stronger signals
were detected for WT and D12N AAPs than for the FS AAP (Fig.
4B, lanes 2 and 5 versus lane 8 and lanes 1 and 4 versus lane 7), with
WTAAP showing the strongest signals overall. These data showed
thatWT andD12NAAPs exhibited greater intrinsic stalling activ-
ity than FS AAP and indicate that evolutionarily conserved ele-
ments in the AAP contribute to intrinsic stalling activity even in
the absence of Arg-stimulated stalling activity.
A question that arises is whether the presence of novel Arg
codons in the AAP coding sequence fortuitously creates new sites
for ribosome stalling within the AAP. If this were so, then this
could account for the detection of internal stall sites with tRNAArg
probe. We tested this by making constructs in which the AAP was
fused in frame with the luciferase coding region. In such con-
structs, for the wild-type AAP, the primary stalling signals ob-
served by toeprinting are in the region downstream of AAP codon
24 (17, 18, 53). We used toeprinting to analyze ribosome stalling
in constructs (see Fig. S1C and Fig. S5 in the supplemental mate-
rial) that contained wild-type AAP sequence or contained muta-
tions D12N, A21R, L22R, N23R, A24R, or *25R (the latter repre-
senting an additional codon in the construct). In each construct,
except for the D12N AAP, increased stalling corresponding to
ribosomes downstream of codon 24 was observed (see Fig. S5).
Additional Arg-regulated stall sites in the AAP coding region ap-
proximately 30 nt upstream could be attributed to ribosomes
stalled behind those primarily stalled by Arg. Importantly, no ad-
ditional toeprint signals corresponding to ribosomes stalled at in-
ternal positions in the AAPs containing A21R, L22R, N23R, and
A24R mutations were observed; thus, these Arg codons did not
create new stalling sites.
The effects of other RAPs on peptidyl transferase function.
We compared the function of the S. cerevisiae AAP (AAPSc) to the
N. crassaAAP (AAPNc) using wheat germ extracts (Fig. 5A and B).
In low Arg, both WT AAPSc-tRNA and WT AAPNc-tRNA disap-
peared rapidly following the addition of puromycin. In high Arg,
for bothWTAAPSc-tRNA andWTAAPNc-tRNA, the rates of pep-
tidyl-tRNA disappearance were lower, suggesting that AAPSc
functioned similarly to AAPNc to inhibit PTC function in response
to Arg. Synthesis of cytomegalovirus gp48 is inhibited by transla-
tion of a 22-codon uORF (gp48 uORF2); the gp48 uORF2 nascent
peptide stalls ribosomes at the uORF2 termination codon (5).
gp48 uORF2 was translated in wheat germ extract, and its effects
on the PTC were tested using the puromycin release assay (Fig.
5C). WT gp48 uORF2-tRNA did not disappear rapidly following
the addition of puromycin (Fig. 5C, lanes 2 and 3 versus lane 1),
indicating that WT gp48 uORF2 inhibited PTC function. How-
ever, in striking contrast, for the nonfunctional gp48 uORF2 con-
taining the P22Amutation, uORF2-tRNA was released rapidly by
puromycin (Fig. 5C, lanes 5 and 6 versus lane 4). Thus, in contrast
to results with the AAP, where the identity of the C-terminal
amino acid had little impact on inhibition of puromycin release,
gp48 uORF2 Pro-22 was crucial for this function. The inhibition
of nascent chain release by AAP in high Arg and gp48 uORF2 was
directly compared for an extended period of incubation (up to 30
min) in the presence of puromycin. The gp48 uORF2 was more
inhibitory than theAAP (see Fig. S6 in the supplementalmaterial).
These analyses of gp48 uORF2 indicate an effect of this RAPon the
PTCbeyond its known effect on inhibiting the function of eukary-
otic release factor 1 (eRF1) (29). Preparation of samples for
cryo-EM studies by other investigators also indicated that the
gp48 uORF2-induced ribosome stall was highly stable (1). How-
ever, the possibility that the gp48 uORF2-tRNA is released from
the P site but remains associated with ribosomes is another poten-
tial explanation for the observed resistance of gp48 uORF2-tRNA
to cleavage by puromycin (7).
One difference between gp48 uORF2 and AAP is that gp48
uORF2 ends with a Pro residue, and the presence of a Pro residue
in the ribosome P site has been associated with reduced reactivity
FIG 4 Ribosome stalling prior to complete AAP synthesis. (A) A21R, L22R,
N23R, A24R, and *25R indicate that the original codons at AAP positions 21,
22, 23, 24, or 25 were changed, respectively, to CGU Arg codons. AAP25,
AAP24, AAP23, AAP22, and AAP21 indicate that AAP was truncated after posi-
tion 25, 24, 23, 22, or 21. N. crassa extracts were programmed with the indi-
catedRNAs in either a low () or high () concentration ofArg. Sampleswere
taken at time zero and at 1 and 3min after the addition of 0.1 mMpuromycin.
Arrows indicate the position of peptidyl-tRNA. AAP-tRNA was labeled with
[35S]Met (left), or a 32P-labeled tRNAArg (CGU) probe was used (right). (B)
Truncated mRNAs encoding WT AAP, D12N AAP, or frameshift (FS) AAPs,
which contained Arg (CGU) codons at the indicated positions, were translated
in N. crassa extract for 10 min at 26°C. In the upper panel, peptidyl-tRNA
(arrow) was detected with 32P-labeled tRNAArg (CGU) probe. The lower panel
shows a gel analysis to establish that similar amounts of input mRNAs were
used in the translation reactions shown in the upper panel.
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toward puromycin (36).We tested theA24PAAP andD12NA24P
AAP in the puromycin release assay (see Fig. S6 in the supplemen-
tal material). The AAP A24P mutation did not decrease reactivity
to puromycin in either the wild-type or D12N AAP context.
DISCUSSION
The nascent AAP interferes with PTC function in the presence of
high Arg. Arg-regulated inhibition of PTC function was observed
for full-length AAP, for AAP extended by one amino acid at its C
terminus (AAP25), and for AAP truncated by one or two amino
acids at its C terminus (AAP23 orAAP22, respectively) (Fig. 3A, 4A,
and 5A). These truncated AAPs, like the full-length AAP, caused
regulatory ribosome stalling in response to Arg, albeit with re-
duced efficiency (Fig. 3B and C). Analyses of tRNA identity also
showed that the AAP regulated PTC function prior to its complete
synthesis. These results demonstrate that the AAP has the unusual
property of interfering with the PTC across a window spanning at
least four consecutive codons (AAP codons 22 to 25). We also
obtained data indicating that both wild-type AAP and D12N AAP
(which lacks regulatory function) had higher intrinsic stalling ac-
tivity than a frame-shifted peptide. Thus, the AAP appears to have
intrinsic stalling activity detectable even in the absence of Arg-
regulated stalling.
Ribosomes containing AAP24 synthesized in a low concentra-
tion of Arg but then subsequently incubated with high Arg show a
change in the relative conformation of the AAPwith respect to the
ribosome (61) and a reduction in PTC function (Fig. 1F). These
data support the idea that the Arg-induced change in relative con-
formation of AAP with respect to the ribosome is necessary to
provide the capacity for AAP to interfere with the PTC.
Why does the full-length AAP stall ribosomes more efficiently
than AAPs truncated at their C termini? It is not the absolute
length of the nascent AAP because while C-terminal truncations
AAP23 and AAP22 reduced the efficiency of ribosome stalling
based on reporter synthesis and toeprint assays (Fig. 3B and C),
N-terminal truncations yielding even shorter AAPs do not (18).
Possibly, in high Arg, when the ribosome translating AAP22 or
AAP23 is stalled because the ribosome has reached the 3= end of a
truncated mRNA, AAP22 or AAP23 nascent peptides have suffi-
cient opportunity to obtain proper register with respect to the
ribosome so that, like AAP24, they can interfere with PTC func-
tion. Important in this regard, the relative conformations of each
of these C-terminally truncated AAPs also change with respect to
the ribosome in response to Arg (61). However, if the mRNA
extends past codon 22 or codon 23 because AAP22 and AAP23
might not adapt or maintain register as efficiently as AAP24, the
ribosome translates past codon 22 and codon 23. There is some
stalling of ribosomes that are engaged in elongation at these
codons, however, as determined by the detection of stabilized
AAP-tRNAArg for L22R AAP24 and N23R AAP24 (Fig. 4). In con-
trast, AAP21, which undergoes an Arg-dependent conformational
change with respect to the ribosome (61), cannot find the proper
register to interfere with the PTC (Fig. 3 and 4). These data suggest
amodel for AAP-mediated stalling in response to Arg inwhich the
AAP undergoes a change in relative conformation with respect to
the ribosome, and this altered conformation must be in proper
register with the ribosome to efficiently interfere with PTC func-
tion. In this model, there is a window of AAP chain lengths for
which AAP can find the register (with respect to the ribosome and
possibly with respect to Arg), with the wild-type AAP length being
FIG 5 The S. cerevisiae AAP and CMV gp48 uORF2 peptide interfere with
puromycin release. (A) Truncated mRNAs specifying S. cerevisiae (Sc) WT
AAP andN. crassa (Nc) WT AAP were translated in wheat germ extract. Sam-
ples were taken at time zero and at 1 and 3 min after the addition of 1 mM
puromycin. Translation reactionmixtures contained low () or high () Arg.
Arrows, [35S]Met-labeled AAP-tRNA. (B) Quantification of puromycin re-
lease assay of AAPSc-tRNA and AAPNc-tRNA in wheat germ extract. The sig-
nals representing peptidyl-tRNAs at 1 and 3min were normalized to the signal
at time zero. Mean values and standard deviations from three independent
translation reactions are given (**, P 0.01; ***, P 0.001, Student’s t test).
(C) The effect of CMV gp48 uORF2 on peptidyl-tRNA release by puromycin.
WT gp48 uORF2 peptide and the nonfunctional mutated P22A gp48 uORF2
were tested inwheat germ extract. Samples were taken at time zero and at 1 and
3 min after the addition of 1 mM puromycin. Arrow, [35S]Met-labeled
uORF2-tRNA; arrowhead, [35S]Met-labeled free uORF2 and uORF2-puro-
mycin. (D) The signals representing gp48 uORF2-tRNAs at 1 and 3 min were
normalized to the signal at time zero. Mean values and standard deviations
from three independent translation reactions are given.
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most efficient at achieving and/or maintaining this proper regis-
ter. Consistent with this idea, of 120 uORF-encoded AAPs identi-
fied by evolutionary conservation, the C-terminal regions of 119
are at least as long as the N. crassa AAP C terminus, and none is
more than two residues longer (49).
How is PTC function affected by AAP and Arg to inhibit the
function of puromycin? There are at least several ways that access
of puromycin to the ribosome A site could be restricted. There
could be failure of translocation (Fig. 6, steps 2 and 3), or the
structure of the ribosome could be altered such that access to the
empty A site is blocked (Fig. 6D, step 4). Alternatively, puromycin
could enter the ribosome A site (Fig. 6E), but the peptidyl trans-
ferase reaction is inhibited (Fig. 6, step 5). Toeprint analyses of
mRNAs on which the AAP stalls ribosomes at its termination
codon show that the termination codon is in the A site, indicating
that stalling occurs with a configuration of the ribosome depicted
in Fig. 6D. Furthermore, AAP can be fully synthesized in low Arg
and still interfere with PTC function when Arg is subsequently
added (Fig. 1F). These data indicate that Arg’s inhibitory effect on
PTC function occurs after translocation (after step 3 in Fig. 6).
Thus, the relative conformation of the AAP in the ribosome in
high Arg could restrict access to the empty A site (Fig. 6, step 4)
and/or could interfere with the peptidyl transferase reaction (Fig.
6, step 5). The cryo-EM model of the wheat ribosome containing
AAP in the absence of Arg raises the possibility that an altered
position of ribosomal protein L10e could be responsible for inhib-
iting PTC function (1).
Unlike many other RAPs, specific residues of the AAP are not
required at or near the PTC for the AAP to cause ribosome arrest.
For example, the C-terminal Pro-22 of CMV uORF2 is crucial for
stalling (4) and for inhibiting PTC function, based on the puro-
mycin release assay (Fig. 5B). SecM, MifM, TnaC, and ErmAL1
each require specific amino acids at the PTC for stalling to occur
(9, 23, 37, 44). ErmCL, ErmAL1, and SecM each also require
nearby amino acids (2 relative to the nascent peptide C termi-
nus) for stalling to occur (44, 63). In contrast, AAP residues 9 to 20
are sufficient to confer regulatory function; moreover, AAP resi-
dues 21 to 24 can all be replaced with Ala, and AAP function is
retained (49). Furthermore, the evolutionary conservation of res-
idues of the AAP beyond Arg-20 is relatively low.
In summary, we showhere that theAAP interferes directlywith
PTC function in response to Arg. The AAP is an evolutionarily
conserved, uORF-encoded regulatory peptide, and there is ex-
panding appreciation of the wider roles for uORFs in controlling
gene expression. The AAP represents an unusual example of nas-
cent peptide control of ribosome activity because there is no evi-
dent requirement for specific nascent peptide residues to be at or
near the PTC for stalling to occur. The AAP stalls ribosomes from
fungal, plant, and mammalian sources and thus must exert a reg-
ulatory effect through conserved regions of the eukaryotic ribo-
some. Understanding the function of the AAP provides a basis for
gaining insight into fundamental processes by which nascent pep-
tides and metabolites regulate gene expression.
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